Organización: Universidad de Navarra

Doctor by the Universidad de Navarra with the thesis Yes1 drives tumor growth and progression and predicts sensitivity to dasatinib in non-small cell lung cancer 2018. Supervised by Dr. Luis Montuenga Badía, Dr. Jackeline Agorreta Arrazubi.